Outcome of Laparoscopic Total Mesorectal Excision Versus Open Technique in Management of Rectal Carcimoma

Sponsor
Sohag University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05685680
Collaborator
(none)
50
1
2
12
4.2

Study Details

Study Description

Brief Summary

Colorectal cancer is the second leading cause of death in the West, and rectal cancer accounts for about 25% of colon cancers

Low anterior resection has been the mainstay of rectal cancer surgery in low rectal cancer since the 1970s. Although the best efforts of experienced surgeons, The local recurrence rate is 3 to 33% in conventional surgery, while total mesorectal excision (TME) results indicate a recurrence rate of less than 10%

The evolution of the concept of TME which was first revealed by Heald.in 1982 made a major shift in the treatment strategies (Rodriguez-Luna et al,2015). The concept of TME was the most important event in surgery for rectal cancer in the last two decades, because even without a curative approach, the local recurrence decreased to 6 to 12%, and 5-year survival improved by 53-87% TME described clear definitions of distal resection margin (DRM), circumferential resection margin (CRM), and least number of harvested lymph nodes, so oncological outcomes improved, locoregional recurrence and survival rates also influenced .

Laparoscopic total mesorectal excision (LTME) may be associated with less blood loss, earlier recovery, and lower morbidity. Identification of the small nerves and vessels became easiear because of laparoscopic magnified view of pelvis and thus prevents these injuries (Sajid et al, 2019). Also, minimal surgical trauma will reduce the immunologic response and preserves postoperative immunologic defenses. This may lead to low rate of infections as well as low local recurrences and distant metastases in addition to, tissue handling with less manipulation, 'may reduces the spread of cancer cells

TME in obese males with low and anterior rectal tumors is technically challenging especially post neoadjuvant chemoradiotherapy due to distortion of the anatomical planes (Ng et al, 2014). In these patients, it is difficult to obtain a proper view of the dissection plane, in open technique which threatens the integrity of TME and carries the risk of positive margins, which is related to higher rates of local recurrence

LTME is a widely used approach for rectal cancers; although conversion rate varies from 1.2 to 17%, and it is higher if BMI is equal to or more than 30

Condition or Disease Intervention/Treatment Phase
  • Procedure: total mesorectal excision in rectal carcinoma
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Outcome of Laparoscopic Total Mesorectal Excision Versus Open Technique in Management of Rectal Carcinoma
Actual Study Start Date :
Dec 20, 2022
Anticipated Primary Completion Date :
Dec 20, 2023
Anticipated Study Completion Date :
Dec 20, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Group A laparoscopic group

group A laparoscopic surgery

Procedure: total mesorectal excision in rectal carcinoma
total mesorectal excision laparoscopic versus open technique in management of rectal carcinoma

Active Comparator: Group B

Group B open surgery

Procedure: total mesorectal excision in rectal carcinoma
total mesorectal excision laparoscopic versus open technique in management of rectal carcinoma

Outcome Measures

Primary Outcome Measures

  1. Comparison betewen laparoscopic and open teqnique in resection of rectal carcinoma and the involvement of the resection margin (R1), which is CRM involvement or DRM involvement.after resection. [1year]

    R(resection margin of cancer of rectum) CRM circumferencial margin Or. DRM distal resection margin of cancer

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • All patients with pathologically confirmed rectal carcinoma involving middle or lower third rectum and operable by MRI and CT scan criteria.

  • Both sexes will be included.

  • Age: ranging from 20 to 70 years.

Exclusion Criteria:
  • Patients with stage IV.

  • Recurrent rectal cancers.

  • Combined malignancy.

  • Patients admitted due to emergency situations (acute large bowel obstruction, abdominal abscess, or rectal perforation and hemorrhage).

  • Patients with contraindication for laparoscopic surgery.

  • Unfit patients (ASA score > II).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sohag University Hospital Sohag Egypt

Sponsors and Collaborators

  • Sohag University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Osama Saleh Ahmed, Assistant lecture ofgeneral surgery, Sohag University
ClinicalTrials.gov Identifier:
NCT05685680
Other Study ID Numbers:
  • Soh-Med-22-12-17
First Posted:
Jan 17, 2023
Last Update Posted:
Jan 17, 2023
Last Verified:
Dec 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 17, 2023